Oral Answers to Questions

Debate between Wendy Morton and Jamie Wallis

Tuesday 19th January 2021 Commons Chamber

[Wendy Morton]

The UK believes that a robust and fair intellectual property system is a key part of the innovation framework that allows economies to grow and become innovators, while enabling society to benefit from knowledge and ideas. We believe that non-exclusive voluntary licensing has advantages over compulsory licensing, because it creates a sounder basis for long lasting beneficial relationships and incentives to create and commercialise new inventions such as those life-changing vaccines.

[Dr Wallis [V]]

I thank the Minister for her answer. What steps is her Department taking to ensure that the poorest and most disadvantaged countries have access to vaccines?

[Wendy Morton]

I think this goes to the heart of this particular question today. Our commitment will support access to covid-19 vaccines for up to 92 developing countries by contributing to the supply of 1 billion doses in 2021. That is only possible through the COVAX AMC facility, which we have been leading on from the front with our big commitment of £548 million to that facility and the encouragement of others to step up to the mark and reach the $1 billion target, too.

Oral Answers to Questions

Debate between Wendy Morton and Jamie Wallis

Tuesday 30th June 2020 Commons Chamber

[The Parliamentary Under-Secretary of State for Foreign and Commonwealth Affairs (Wendy Morton)]

Finding a covid-19 vaccine is a top priority for the Government. The Prime Minister has set up a vaccine taskforce and appointed Kate Bingham to lead it. The taskforce aims to secure access to promising vaccines for the UK population and to support access to vaccines to help bring the pandemic to an end. We have invested more than £130 million in research for the vaccine front-runners at the University of Oxford and Imperial College, London, and this is in addition to the £250 million that we have contributed to the Coalition for Epidemic Preparedness Innovations and the £1.65 billion to Gavi, the Vaccine Alliance.

[Dr Wallis]

I thank the Minister for her answer. Does she agree that central to the development of a vaccine is ensuring equitable access for all, particularly for those countries whose health systems are most fragile?